|
|
|
Volumn 22, Issue SUPPL. 5, 1995, Pages 5-21
|
|
Treatment of metastatic breast cancer: Present and future prospects
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
AMINOGLUTETHIMIDE;
AMONAFIDE;
AROMATASE INHIBITOR;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DIETHYLSTILBESTROL;
DOCETAXEL;
DOXORUBICIN;
ESTROGEN RECEPTOR;
ETOPOSIDE;
FLUOROURACIL;
FLUOXYMESTERONE;
FOLINIC ACID;
GROWTH FACTOR RECEPTOR;
MEGESTROL ACETATE;
METHOTREXATE;
MIFEPRISTONE;
MITOMYCIN C;
NAVELBINE;
PACLITAXEL;
PERFLUOROOCTYL BROMIDE;
PREDNISONE;
PROGESTERONE RECEPTOR;
SEMUSTINE;
TOREMIFENE;
VINBLASTINE;
BREAST METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
GENE THERAPY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MEDICAL DECISION MAKING;
OVARIECTOMY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASM METASTASIS;
NEOPLASMS, HORMONE-DEPENDENT;
PALLIATIVE CARE;
|
|
EID: 0029020450
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (74)
|
|
References (0)
|
